Nursing and Health Professions
Inpatient
83%
Radiotherapy
75%
Intensity Modulated Radiation Therapy
58%
Control
50%
Nasopharynx Carcinoma
41%
Overall Survival
25%
Progression Free Survival
25%
Treatment Outcome
8%
Follow up
8%
Survival Rate
8%
Chemotherapy
8%
Hospital
8%
Chemoradiotherapy
8%
Toxicity
8%
Distant Metastasis
8%
Propensity Score
8%
Procedures
8%
Dose
8%
Enalapril Maleate
8%
Analysis
8%
Patient History of Surgery
8%
Medicine and Dentistry
Patient
100%
Radiation Therapy
75%
Intensity Modulated Radiation Therapy
58%
Nasopharynx Carcinoma
41%
Overall Survival
25%
Progression Free Survival
25%
Propensity Score Matching
16%
Therapeutic Procedure
16%
Prognostic Factor
8%
Survival Rate
8%
Follow up
8%
Toxicity
8%
Distant Metastasis
8%
Chemoradiotherapy
8%
Patient History of Surgery
8%
Analysis
8%
Enalapril Maleate
8%
Pharmacology, Toxicology and Pharmaceutical Science
Nasopharynx Carcinoma
41%
Overall Survival
25%
Progression Free Survival
25%
Toxicity
8%
Survival Rate
8%
Distant Metastasis
8%
Patient History of Surgery
8%
Enalapril Maleate
8%
Immunology and Microbiology
Overall Survival
25%
Progression Free Survival
25%
Survival Rate
8%
Dose
8%
Biochemistry, Genetics and Molecular Biology
Overall Survival
25%
Progression Free Survival
25%
Survival Rate
8%
Dose
8%